Prognostic Factors in Patients with Pathological and N2 Non-Small Cell Lung Cancer

被引：2
|
作者：
Saito, Makoto [1 ]
Kato, Harubumi [2 ]
机构：
[1] Tokyo Med Univ, Kasumigaura Hosp, Dept Chest Surg, Amimachi, Ibaraki 3000395, Japan
[2] Tokyo Med Univ, Dept Surg, Tokyo, Japan
来源：
ANNALS OF THORACIC AND CARDIOVASCULAR SURGERY | 2008年 / 14卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1 / 2
页数：2
相关论文
共 50 条
  • [41] Integral mediastinal staging in patients with NON-SMALL cell lung cancer and risk factors for occult N2 disease
    Lucena, Carmen M.
    Martin-Deleon, Roberto
    Boada, Marc
    Marrades, Ramon M.
    Sanchez, David
    Sanchez, Marcelo
    Vollmer, Ivan
    Martinez, Daniel
    Fontana, Ainhoa
    Reguart, Noemi
    Molins, Laureano
    Agusti, Carlos
    RESPIRATORY MEDICINE, 2023, 208
  • [42] Editorial: Prognostic factors in non-small cell lung cancer
    Rahouma, Mohamed
    Baudo, Massimo
    Zhang, Jun
    Mutti, Luciano
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [43] Prognostic factors in non-small cell lung cancer surgery
    Birim, Ö
    Kappetein, AP
    van Klaveren, R
    Bogers, AMC
    EJSO, 2006, 32 (01): : 12 - 23
  • [44] Surgical Resection of Non-Small Cell Lung Cancer with N2 Disease
    Donington, Jessica S.
    Pass, Harvey I.
    THORACIC SURGERY CLINICS, 2014, 24 (04) : 449 - +
  • [45] Management of Stage IIIA (N2) Non-Small Cell Lung Cancer
    Gillaspie, Erin A.
    Wigle, Dennis A.
    THORACIC SURGERY CLINICS, 2016, 26 (03) : 271 - +
  • [46] N2 institutional consensus on Non-Small Cell Lung Cancer (NSCLC)
    Eid, H.
    El Kik, A.
    Karam, E.
    Chamaa, A.
    Habr, B.
    El Karak, F.
    Kourie, H.
    Azouri, F.
    Smayra, V.
    Aoun, N.
    Kattan, J.
    Chahine, G.
    Ghosn, M.
    Wakim, J.
    Nasserddine, H.
    Nasr, F.
    Khayat, G.
    Nakad, J.
    Harmouche, C.
    Dabar, G.
    Tabet, G.
    Aoun, Z.
    Riachy, M.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [47] PROGNOSIS OF SKIP N2 NON-SMALL CELL LUNG CANCER (NSCLC)
    Chang, Y.
    Cho, D.
    Choi, S.
    CHEST, 2020, 157 (06) : 23A - 23A
  • [48] TREATMENT OF N2 NON-SMALL CELL LUNG-CANCER (NSCLC)
    KLASTERSKY, J
    FELD, R
    KLEISBAUER, JP
    ROCMANS, P
    CHEST, 1989, 96 (01) : S83 - S85
  • [49] Clinical predictors of N2 disease in non-small cell lung cancer
    Takamochi, K
    Nagai, K
    Suzuki, K
    Yoshida, J
    Ohde, Y
    Nishiwaki, Y
    CHEST, 2000, 117 (06) : 1577 - 1582
  • [50] Prognostic Heterogeneity in Multilevel N2 Non-Small Cell Lung Cancer Patients: Importance of Lymphadenopathy and Occult Intrapulmonary Metastases
    Sakao, Yukinori
    Okumura, Sakae
    Mun, Mingyon
    Uehara, Hirofumi
    Ishikawa, Yuichi
    Nakagawa, Ken
    ANNALS OF THORACIC SURGERY, 2010, 89 (04): : 1060 - 1063
12345